AMRN
Amarin Corporation plc
NASDAQ · Healthcare · Biotechnology · IE
$13.63
−0.58%Margins
Gross margin
41.6%
EBITDA margin
-10.6%
EBIT margin
-17.9%
Net margin
-14.6%
FCF margin
26.4%
-6.1%
Return on equity
-4.3%
Return on assets
-7.4%
Return on invested capital
0.29x
Asset turnover
$49.2M
Cash from operations
$15
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026